{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T01:19:38Z","timestamp":1778289578488,"version":"3.51.4"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.amjcard.2006.08.044","type":"journal-article","created":{"date-parts":[[2006,12,9]],"date-time":"2006-12-09T12:14:56Z","timestamp":1165666496000},"page":"379-381","source":"Crossref","is-referenced-by-count":37,"title":["Safety of Lovastatin\/Extended Release Niacin Compared With Lovastatin Alone, Atorvastatin Alone, Pravastatin Alone, and Simvastatin Alone (from the United States Food and Drug Administration Adverse Event Reporting System)"],"prefix":"10.1016","volume":"99","author":[{"given":"Alawi A.","family":"Alsheikh-Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard H.","family":"Karas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2006.08.044_bib1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2006.08.044_bib2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1161\/01.CIR.0000114834.85476.81","article-title":"Evidence-based guidelines for cardiovascular disease prevention in women","volume":"109","author":"Mosca","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2006.08.044_bib3","doi-asserted-by":"crossref","first-page":"3K","DOI":"10.1016\/j.amjcard.2005.08.002","article-title":"Reducing residual risk for patients on statin therapy: the potential role of combination therapy","volume":"96","author":"Davidson","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2006.08.044_bib4","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/archinte.164.7.697","article-title":"New perspectives on the use of niacin in the treatment of lipid disorders","volume":"164","author":"McKenney","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2006.08.044_bib5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0002-9149(94)90005-1","article-title":"Comparative efficacy and safety of pravastatin, nicotinic acid and the two combined in patients with hypercholesterolemia","volume":"73","author":"Davignon","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2006.08.044_bib6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1750-3639.1999.tb00607.x","article-title":"Case of the month: February 1999\u201454 year old man with severe muscle weakness","volume":"9","author":"Hill","year":"1999","journal-title":"Brain Pathol"},{"key":"10.1016\/j.amjcard.2006.08.044_bib7","doi-asserted-by":"crossref","first-page":"597","DOI":"10.7326\/0003-4819-109-7-597_2","article-title":"Lovastatin, nicotinic acid, and rhabdomyolysis","volume":"109","author":"Reaven","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2006.08.044_bib8","doi-asserted-by":"crossref","first-page":"29U","DOI":"10.1016\/S0002-9149(98)00732-2","article-title":"A new extended-release niacin (Niaspan): efficacy, tolerability, and safety in hypercholesterolemic patients","volume":"82","author":"Morgan","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2006.08.044_bib9","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jama.1994.03510330050033","article-title":"A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients","volume":"271","author":"McKenney","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2006.08.044_bib10","first-page":"III-813","article-title":"Relative safety of extended-release niacin versus other niacin formulations (abstr)","volume":"110","author":"Alsheikh-Ali","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2006.08.044_bib11","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/S0002-9149(02)02334-2","article-title":"Risk of adverse events with concomitant use of atorvastatin or simvastatin and glucose-lowering drugs (thiazolidinediones, metformin, sulfonylurea, insulin, and acarbose)","volume":"89","author":"Alsheikh-Ali","year":"2002","journal-title":"Am J Cardiol"},{"issue":"suppl A9","key":"10.1016\/j.amjcard.2006.08.044_bib12","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.amjcard.2004.02.045","article-title":"Adverse events with concomitant use of simvastatin or atorvastatin and thiazolidinediones","volume":"93","author":"Alsheikh-Ali","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2006.08.044_bib13","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.amjcard.2004.06.033","article-title":"Risk of adverse events with fibrates","volume":"94","author":"Alsheikh-Ali","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2006.08.044_bib14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1520-037X.2005.4060.x","article-title":"Adverse events with concomitant amiodarone and statin therapy","volume":"8","author":"Alsheikh-Ali","year":"2005","journal-title":"Prev Cardiol"},{"key":"10.1016\/j.amjcard.2006.08.044_bib15","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1161\/CIRCULATIONAHA.105.555482","article-title":"The safety of rosuvastatin as used in common clinical practice: a postmarketing analysis","volume":"111","author":"Alsheikh-Ali","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2006.08.044_bib16","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.289.13.1681","article-title":"Statin-associated myopathy","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914906020698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914906020698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T00:29:02Z","timestamp":1547166542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914906020698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0002914906020698"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2006.08.044","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}